THE EFFECT OF A GONADOTROPIN-RELEASING HORMONE AGONIST ANALOG (NAFARELIN) ON BONE METABOLISM

被引：179
|
作者：
JOHANSEN, JS
RIIS, BJ
HASSAGER, C
MOEN, M
JACOBSON, J
CHRISTIANSEN, C
机构：
[1] NATL HOSP, DEPT OBSTET & GYNECOL, OSLO, NORWAY
[2] SODERTALJE HOSP, DEPT OBSTET & GYNECOL, SODERTALJE, SWEDEN
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1988年 / 67卷 / 04期
关键词：
D O I：
10.1210/jcem-67-4-701
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：701 / 706
页数：6
相关论文
共 50 条
  • [1] ABSORPTION AND METABOLISM OF NAFARELIN, A POTENT AGONIST OF GONADOTROPIN-RELEASING HORMONE
    CHAN, RL
    HENZL, MR
    LEPAGE, ME
    LAFARGUE, J
    NERENBERG, CA
    ANIK, S
    CHAPLIN, MD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (03) : 275 - 282
  • [2] TREATMENT OF ENDOMETRIOSIS WITH A POTENT AGONIST OF GONADOTROPIN-RELEASING HORMONE (NAFARELIN)
    SCHRIOCK, E
    MONROE, SE
    HENZL, M
    JAFFE, RB
    [J]. FERTILITY AND STERILITY, 1985, 44 (05) : 583 - 588
  • [3] Gonadotropin-releasing hormone agonist analog (Nafarelin): A useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism
    Kletter, GB
    RolfesCurl, A
    Goodpasture, JC
    Solish, SB
    Scott, L
    Henzl, MR
    Beitins, IZ
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1996, 9 (01): : 9 - 19
  • [4] EFFECT ON CORPUS-LUTEUM FUNCTION OF LUTEAL PHASE ADMINISTRATION OF A POTENT GONADOTROPIN-RELEASING HORMONE ANALOG (NAFARELIN)
    SCHRIOCK, ED
    MONROE, SE
    MARTIN, MC
    HENZL, MR
    JAFFE, RB
    [J]. FERTILITY AND STERILITY, 1985, 43 (06) : 844 - 850
  • [5] Gonadotropin-releasing hormone analog therapeutics
    Newton, Claire L.
    Riekert, Carmen
    Millar, Robert P.
    [J]. MINERVA GINECOLOGICA, 2018, 70 (05): : 497 - 515
  • [6] Negative regulation of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression by a gonadotropin-releasing hormone agonist in the rat hypothalamus
    Han, YG
    Kang, SS
    Seong, JY
    Geum, D
    Suh, YH
    Kim, K
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 1999, 11 (03) : 195 - 201
  • [7] TREATMENT OF HIRSUTISM WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST (NAFARELIN)
    ANDREYKO, JL
    MONROE, SE
    JAFFE, RB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04): : 854 - 859
  • [8] Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration
    Taga, M
    Minaguchi, H
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1996, 75 (02) : 162 - 165
  • [9] Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone
    Palomba, S
    Morelli, M
    Di Carlo, C
    Noia, R
    Pellicano, M
    Zullo, F
    [J]. FERTILITY AND STERILITY, 2002, 78 (01) : 63 - 68
  • [10] USE OF A GONADOTROPIN-RELEASING HORMONE AGONIST ANALOG FOR TREATMENT OF CYCLIC AUDITORY DYSFUNCTION
    ANDREYKO, JL
    JAFFE, RB
    [J]. OBSTETRICS AND GYNECOLOGY, 1989, 74 (03): : 506 - 509
12345